COVID-19: Vaccines and Therapeutics

May 9, 2022
The guidance is intended to help state policymakers identify and address related issues during and after the public health emergency.
May 6, 2022
Based on an updated analysis, FDA said the risk of thrombosis with thrombocytopenia syndrome warrants limiting the vaccine to certain adults.
May 5, 2022
This webinar rural hospital executives and board leaders discuss how boards can work with all levels within their communities.
May 4, 2022
The report estimates the impact of COVID-19 vaccination during a five-month period shortly after the first vaccine was authorized and recommended for health care workers and elderly people in long-term care facilities.
Apr 28, 2022
Moderna today asked the Food and Drug Administration to authorize for emergency use its COVID-19 vaccine in children aged 6 months through 5 years.
Apr 26, 2022
Starting this week, the Administration will allow all pharmacies in the federal pharmacy program to order free oral antiviral treatments directly from the federal government, the White House announced today.
Apr 26, 2022
Advisory updates health care providers, others on recommended therapies for COVID-19.
Apr 25, 2022
The Food and Drug Administration today expanded its approval for remdesivir (Veklury) to include pediatric patients under age 12 who test positive for SARS-CoV-2 and are hospitalized or at high risk of progressing to severe COVID-19. The patient must be at least 28 days old and weigh at least…
Apr 19, 2022
Unvaccinated children aged 5-11 were twice as likely as vaccinated children to be hospitalized for COVID-19 in the first few months of the omicron wave, the study found.
Apr 18, 2022
FDA and HHS authorized extending the shelf life for certain products stored at the right temperatures.